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Collagen is the major structural protein of connective tissues, comprising the 
bulk of the protein in the extracellular matrix. Several studies have shown that 
collagen is also membrane bound in chick (1), rat (2),  and mouse L-cell fibro- 
blasts  (3). Antibodies to membrane-bound collagen have been shown to evoke 
complement (C)-dependent cytotoxicity (1). These reports indicate that collagen 
synthesized by these fibroblasts may be deposited as fibrils in the extracellular 
matrix and also may be bound to the fibroblast membrane. 
Normal human skin fibroblasts have been shown to synthesize at least two 
genetically distinct types of collagen (4, 5). In this report, we present immuno- 
logic evidence that two antigenic types of collagens, type I collagen and a new 
collagen, type M (membrane) collagen, are associated with the normal human 
fibroblast membrane,  and that  antibodies  to one  of these  collagens,  type  M 
collagen, can induce C-mediated cytotoxicity. 
Materials and Methods 
Preparation of Collagen Antigens.  Type I collagen was prepared by acid extraction of human 
skin and purified according to the method of Bornstein and Piez (6). To obtain type III and type M 
collagen antigens, human placentas were pepsin digested and the supernate was sequentially salt 
precipitated at neutral pH with 0.15 M, 1.5 M, and 2.5 M NaC1. The type III collagen was further 
purified by carboxymethylcellulose (CMC) chromatography (7-9). Type I and type III collagens 
were judged to be pure by sodium dodecyl sulfate (SDS) 1 polyacrylamide gel electrophoresis (10) 
and amino acid analysis (7). Pepsin-treated type I collagen was prepared as previously described 
(5,  8,  9). 
Preparation of Antibodies to the Purified Collagens.  Antibodies were raised by subcutaneous 
immunization of rabbits with 5-10 mg of heat-denatured collagen in 1.0 ml of 0.15 M NaCl, 0.05 
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Tris,  pH  7.5,  to  which  was  added  an  equal  volume of complete  Freund's  adjuvant.  Booster 
injections containing a similar amount of collagen were given at 3-wk intervals. Development of 
antibodies was monitored by Ouchterlony gel diffusion analysis  (11) using the specific collagen 
immunogens. Hyperimmune antisera harvested i wk after the third and fourth booster injections 
were used for the studies in this report. 
In  order  to  prepare  type-specific  antibodies,  the  antisera  were  cross-absorbed  on  affinity 
columns prepared  by coupling specific collagens to Sepharose 4B  as described  previously (12). 
Approximately 20 mg of collagen was bound to 5 ml of settled Sepharose. For absorption,  1 ml of 
antiserum was incubated with 5 ml of the collagen Sepharose slurry at room temperature for 2 h 
and then overnight at 4°C. The unbound antiserum was then separated by filtration, precipitated 
at 40% saturation  with (NH4)2SO4, redissolved in 1 ml of Hanks' balanced salt solution  (HBSS) 
(Grand Island Biological Co., Grand Island, N. Y.), and dialyzed against this solution. 
Radioimmunoassay.  The titers of the antisera were assessed by the ability to bind l~I-labeled 
collagen.  Collagens were  iodinated  by the  lactoperoxidase  method  (13). The reaction  mixture 
consisted  of  40  to  125 ~g  of  collagen,  I  mCi [~25I]Na  (Industrial  Nuclear  Co.,  Inc.,  St.  Louis,  Mo.),  5 
~g  of  lactoperoxidase  (Sigma  Chemical Co.,  St.  Louis,  Mo.  ),  and i  ~l  of  0.88  mM  H202  in  a  total  vol 
of  50  ~l.  Iodination  proceeded for  i  rain  at  room  temperature  and  was  stopped by  the  addition  of  500 
~l  of  0.1%  sodium  azide  in  0.15  M NaCI. The  iodinated  collagens  were  then  separated from  free  'z~I 
on  Sephadex  G-100  and  stored  at  -70°C in  1%  albumin.  The  anticollagen  antisera  were  titered  by  a 
double antibody precipitation  reaction:  100 ~l of  serial  doubling dilutions  of  antiserum made in 
0.15  M  NaCl, 0.05  Tris,  pH 7.4,  were incubated for  24 h at  4°C with 100 ~l  of  12SI-laboled  collagen 
(approximately 15,000  cpm). Immediately  before  the  addition  of  goat  antirabbit  IgG  in  excess,  5 ~g 
of purified nonimmune  rabbit  gamma  globulin  was added as a carrier to ensure complete 
precipitation.  The resultant  precipitates  were harvested after  an additional  24 h at 4°C,  washed 
twice,  and counted in an automatic gamma  scintillation  spectrometer (Nuclear-Chicago Corp., 
Des Plaines,  Ill.).  Titers  were expressed as  the  highest dilution  of  antiserum which bound 50% of 
the maximum  counts precipitated.  The collagen antigens after  iodination,  and the iodinated 
collagens  after  antibody  precipitation  had migration  patterns  similar  to  the  uniodinated antigens 
on autoradiographs of  SDS polyacrylamide gel  electrophoresis,  indicating  that  the  initial  collagen 
antigen, and not a minor contaminant was being assessed in the radioimmunoassay. C fixation 
was assessed  by standard  techniques (14). 
Assay of  Cytotoxicity. Cultured  human skin fibroblasts  (Robel,  CRL 1187;  Elman, CRL 1101; 
Fesin,  CRL 1106;  and HeLa, CRL 2)  were purchased  from the American Type Culture  Collection, 
Rockville,  Md. and were used between the fifth  and tenth passage. All strains  gave identical 
results  in these experiments. Cells  were grown to confluence in Dulbecco-Vogt modified Eagle's 
medium (GIBCO) containing 10% fetal  calf  serum. Human tendon and chick tendon fibroblasts 
were grown and used as primary cultures. 
Cell  counts  were  performed  with  a hemocytometer. For  cytotoxicity  experiments, 2.5 x 10  e  cells 
were  trypsinized,  washed, and  suspended in 1  ml of  HBSS. Depending on the experiment, 25-100 
~l  of  cells  (62,500-250,000  cells)  were incubated with an equal  aliquot  of  antiserum at  37°C for 15 
min. An equal  aliquot  of  a 1:5  dilution  of  guinea  pig  C (GIBCO) was  then  added. After  incubation 
for  an additional  45 min at  37°C,  0.2% trypan blue was added and viability  was assessed. 
In order to assess  the specificity  of the C-mediated cytotoxicity,  cells  were pretreated with 
collagenase,  trypsin,  or  chymotrypsin  before  the  addition  of  antibody  and  C. Bacterial  collagenase 
(type  III)  was purchased from Advanced Biofactors.  Since commercial collagenase  preparations 
have shown to  contain nonspecific  proteases (15),  the  purity  of  this  preparation was ascertained. 
The  collagenase  used  in  this  study  was  judged  to  be  pure  by  the  following  criteria:  it  gave  a doublet 
band  on  5%  SDS  gel electrophoresis  of 105,000, released no  [3H]tryptophan  counts  from 
[3H]tryptophan-labeled fibroblast  proteins, and there was no alteration  of the migration of 
albumin on 5% SDS gel electrophoresis  aRer collagenase  digestion.  Trypsin and chymotrypsin 
were purchased from Sigma Chemical Co. 
Indirect  Immunofluorescence.  For  indirect  immunofluorescence, 100  mg of  a gamma globulin 
fraction  of  goat  antirabbit  IgG was reacted overnight at  4°C with 5 mg of  fluorescein  isothiocya- 
nate (FITC) (Sigma Chemical Co.)  in  0.1  M  NasCO3, pH 9.0.  Separation of  FITC-labeled material 
was accomplished  on Sephadex G-25.  Staining was accomplished using  500/~l  of  trypsinized  cells 
suspended in HBSS containing 0.61% NaN2 which were incubated with 50-/~I  dilutions  of the 
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incubated with a  1:100 dilution of the fluorescent goat antirabbit IgG for 30 rain at 4°C.  The cells 
were washed three times in HBSS, 0.1% NAN2, dried on cover slips, and mounted on slides in 90% 
buffered glycerol. Cells were observed and photographed in a  Leitz orthoflux fluorescence micro- 
scope with epilumination (E. Leitz Inc., Rockleigh, N. J.). 
Results 
In an effort to immunologically dissect the types of collagen bound to the 
normal human fibroblast cell membrane, type I  and type HI collagens were 
purified  to  prepare  type-specific antibodies.  In  the  course  of the  placental 
preparation of type III collagen, it was found that another distinct collagen, type 
M collagen, which was more antigenic than type III collagen, copurified with 
type III collagen. Type III and type M collagen could be partially separated by 
differential salt fractionation, since the majority of the type IH was precipitated 
with 1.5 M salt, while most of the type M was precipitated by 2.5 M salt. Amino 
acid analysis indicated that type M is a collagen, since approximately 1/3 of the 
amino acids are glycine, it has a high content of proline and hydroxyproline, and 
hydroxylysine  is present. Since this collagen is chemically and immunologically 
distinct from type I and type HI collagens, we refer to it as type M (membrane) 
collagen. A full report of the chemical and immunologic characteristics of type 
M collagen is in preparation. 
Antisera and purified specific antibodies used for these studies were titrated 
using a double antibody radioimmunoassay. As shown in Table I, before absorp- 
tion with type-specific collagen bound to Sepharose, antitype M collagen antise- 
rum cross-reacts with ~2SI-labeled type I collagen at a 1:200 dilution. Similarly, 
antitype M  collagen antiserum binds  ~SI-labeled  type I  collagen at  a  1:700 
dilution.  Ouchterlony analysis  showed  that  the  unabsorbed  antisera  cross- 
reacted with both of these collagens. By absorption with type-specific collagens, 
it was possible to obtain specific antitype I and antitype M collagen as judged by 
monospecific precipitin lines in Ouchterlony plates and binding of only a single 
type of collagen in the radioimmunoassay (Table I). Native and denatured type I 
and type III collagens and pepsin-treated type I collagen failed to inhibit the 
binding of l~SI-labeled type M collagen by antitype M collagen in the radioimmu- 
noassay. 
Indirect immunofluorescence,  whether performed with antitype M antiserum, 
antitype I antiserum, specific antitype M, or with specific antitype I collagen 
antibodies, showed a speckled fluorescence  pattern in all cells (Fig.  1). Immuno- 
fluorescence with antitype I collagen antiserum and specific antitype I collagen 
antibodies was abolished at a dilution of 1:50, while immunofluorescence with 
antitype M collagen antiserum was present to a dilution of 1:6,250. Antibodies to 
both type I and type M collagens bound C as assessed by standard C fixation 
techniques (Table I). 
Since certain antibodies to fibroblast membrane proteins have been shown to 
elicit  C-mediated cytotoxicity (16), we  attempted  to  ascertain  whether the 
anticollagen antibodies were cytotoxic. Antitype M collagen antiserum in the 
presence of C completely lysed cultured human skin fibroblasts to a 1:8 dilution, 
while antitype I collagen antiserum had maximally a 20% cytotoxic effect, and 
control rabbit serum had essentially no cytotoxic effect (Fig. 2).  Specific anti- 
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TABLE I 
Titers of Antibodies to Type I and Type M Collagens 
Radioimmunoassay 
Antiserum  J25I-labeled  Indirect im- 
~25I'labeled  type M colla-  munoflu-  Complement 
type I collagen  fixation  gen  orescence 
1)  Antitype  M  collagen,  1/200  1/12,800  1/6,250  1/2,400 
nonspecific 
2)  Antitype  I  collagen,  1/2,400  1/700  1/50  1/600 
nonspecific 
3)  Antitype  M  collagen,  No binding  1/4,800  1/1,250  Not done 
specific 
4)  Antitype  I  collagen,  1/600  No binding  1/50  Not done 
specific 
Specific activity of the 12~I-labeled type I collagen was 4.4 × l0  S cpm/pg and of the 12SI-labeled type 
M collagen was 2.1  ×  l0  s cpm/~g.  15,000 cpm were used in each tube for the radioimmunoassay. 
Indirect immunofluorescence was performed as indicated in the Materials and Methods. Data are 
expressed as the dilution at which immunofluorescence last appeared.  CF test was performed as 
previously described (14) with 0.1  ~g of type I or type M collagen as antigens. 
cytotoxicity with the specific antibodies could be due to either the decrease in 
titer to type M collagen with purification (Table I) and/or the removal of endoge- 
nous C in the purification of antibodies.  In order to assess the effect of the re- 
moval of endogenous C, control rabbit serum and heat-inactivated rabbit serum 
were incubated with the specific type M  antibodies.  Control rabbit serum in a 
1:1 mixture with specific antitype M antibodies effected complete cytotoxicity, 
while control rabbit serum treated at 56°C for 30 min to denature  C and incu- 
bated with the specific type M antibodies in a  1:1 mixture had no cytotoxic ef- 
fect above that of specific type M antibodies in a 1:1 dilution. These results sug- 
gest that both the removal of endogenous C and the lower titers account for the 
difference in cytotoxicity between the antitype M  antiserum  and the purified 
antitype M collagen antibodies. 
The inability of antitype I collagen antibodies to effect C-mediated cytotoxic- 
ity was apparently not due to the failure to bind C, since antitype I antiserum 
had a  1/600 C fixation (CF) titer compared with a 1/2,400 CF titer for antitype M 
collagen antiserum  (Table I). The fourfold difference in CF titer is probably not 
enough to explain the marked differences in C-mediated cytotoxicity (Fig.  2). 
The inability of antitype I collagen antibodies to induce cytotoxicity was not due 
to  differences in  titer  since  a  sixfold concentration  of the  antibodies  by 40% 
ammonium sulfate precipitation had no C-mediated cytotoxicity above that of 
the unconcentrated antiserum. 
To further  confirm the  specificity of the  cytotoxicity, blocking experiments 
were performed  in  which  type I,  type HI,  or type M  collagen  antigens  were 
preincubated with antiserum to type M collagen before addition of the trypsin- 
ized cultured fibroblasts. Type M collagen effectively blocked cytotoxicity, while 
the addition of native or denatured type I collagen or denatured type III collagen 
had no effect on cytotoxicity (Table II). 
Since the antigen-blocking experiments seemed to indicate that cytotexicity 
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FIG.  1.  Immunofluorescent  staining of human fibroblasts with antitype I and antitype M 
collagen. Fibroblasts were stained by indirect immunofluorescence as described  in the 
Materials and Methods  and examined by phase-contrast and fluorescence  microscopy.  (A 
and B) antitype M, (C and D) antitype I, (E and F) antitype M absorbed with type I, and (G 
and H) antitype I absorbed with type M (original magnification  320 on all photographs). 150  IDENTIFICATION  OF  A  DISTINCT  MEMBRANE  COLLAGEN 
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F1o.  2.  The C-mediated cytotoxicity of control rabbit serum (A _  A), antiserum to type I 
collagen ([3- []), antiserum to type M  collagen (O- O), and specific antibodies to type M 
collagen (O- 0). 
TABLe.  II 
Antigen Inhibition of Cytotoxicity 
Antiserum  Dilution  Antigen  Viable cells 
% 
Control rabbit serum  Undiluted  -  93 
Antitype M collagen  1/4  -  0 
+  1/4  10 ng denatured type I collagen  0 
+  1/4  10 ng native type I collagen  0 
+  1/4  10 ng pepsin-treated type I collagen  0 
+  1/4  10 ng denatured type III collagen  0 
+  1/4  10 ng denatured type M collagen  60 
Cytotoxicity assay was performed as described in the Materials and Methods. For the inhibition 
experiments, the added antigen was preincubated with the antibody for 30 min at 37°C before the 
incubation  of antibody with  cells,  the  mix  was  centrifuged  and  the  supernate  was  added  to 
trypsinized cells in the presence of C. 
block the reaction by pretreating the cells either with bacterial collagenase, 
trypsin, or chymotrypsin. Preincubation of the cells with bacterial collagenase 
devoid of nonspecific protease activity (see Materials and Methods) completely 
abolished the cytotoxic effect (Table III).  In addition,  EDTA, an inhibitor of 
collagenase but  not serine proteases,  abolished the ability of collagenase to 
inhibit cytotoxicity. In contrast, preincubation with trypsin or chymotrypsin  did 
not abolish the C-mediated cytolysis of antitype M collagen antiserum. These 
results indicate that it is specifically the collagen on the fibroblast cell mem- 
brane which elicits the cytotoxic response and that the membrane-bound  type M 
collagen is in the triple helical conformation, since chymotrypsin or trypsin 
under the conditions employed would digest denatured collagen chains. LICHTENSTEIN,  BAUER,  HOYT,  AND  WEDNER  151 
TABLE  III 
Enzymatic Inhibition of the C-Mediated Cytotoxicity of  Antitype M Collagen Antiserum 
Antiserum dilution  Enzyme preincubation  Preincubation time  Viability 
rain  % 
Antitype M 1/4  -  5 
+  Bacterial collagenase  30  75 
+  +  60  91 
+  Bacterial collagenase and EDTA  30  0 
-  EDTA  6O  96 
Antitype M 1/4  -  -  9.5 
+  Trypsin  30  8 
+  +  60  25 
-  +  60  92.3 
+  Chymotrypsin  30  13.4 
+  +  60  33 
-  +  60  88 
Cells were preincuhated with bacterial collagenase (5 units), 0.2% trypsin, or chymotrypsin for the 
indicated times. To inactivate the collagenase, 25 mM EDTA, 0.05 Tris, pH 7.4, was premixed with 
the collagenase. The cells were then centrifuged, washed three times with HBSS, and resuspended 
in HBSS before the addition of antiserum.  Cytotoxicity was then assessed as indicated in the 
Materials and Methods. 
In order to assess whether other proteins normally synthesized  by human skin 
fibroblasts could effect a similar cytotoxic response, C-mediated cytotoxicity  was 
tested  using  specific antibodies  to  human fibroblast  collagenase,  a  protein 
secreted into the culture medium (17). No cytotoxic effect on fibroblasts was 
observed with anticollagenase antisera. 
Finally, the species specificity of the C-mediated cytotoxicity  was tested using 
chick tendon fibroblasts. Antisera to human type I and type M collagens had no 
effect on  the  viability  of these  cells  beyond that  of normal  rabbit  serum. 
Cultured human tendon cells were susceptible to C-mediated cytotoxicity with 
the same titers of antitype M collagen as used with skin fibroblasts. 
Discussion 
Our results  indicate that  both  type  M  collagen and type I  collagens are 
membrane bound in cultured human skin fibroblasts but that only antibodies to 
type M collagen in the presence of C mediate cytotoxicity. Type M collagen is 
immunologically  and chemically  distinct from type I and type III collagens since: 
(a) Specific antibodies to type M collagen bound only 125I-labeled type M colla- 
gen. (b) Specific antibodies to type I collagen failed to bind ~25I-labeled type M 
collagen. (c) Type I collagen and type III collagen failed to inhibit the binding of 
specific antibodies to  l~SI-labeled type M  collagen. (d)  Only type M collagen 
inhibited the C-mediated cytotoxicity  of antibodies to type M collagen. (e) Type I 
collagen and type III collagen failed to inhibit the C-mediated cytotoxicity of 
antibodies to type M collagen. (f) Type M collagen could be separated from type I 
and type HI collagen by differential salt precipitation and ion-exchange chroma- 
tography. 
The amino acid content (not shown) and the mode of preparation preclude 
type M  collagen from being either a  basement membrane collagen,  Clq,  or 152  IDENTIFICATION  OF  A  DISTINCT  MEMBRANE  COLLAGEN 
procollagen.  Thus,  we conclude that type M  is  either a  new genetic type of 
collagen or an antigenically and chemically altered form of type I or type III 
collagen. 
The obliteration of cytotoxicity by pretreatment of the fibroblast with purified 
bacterial collagenase and the failure of pretreatment with trypsin and chymo- 
trypsin to modify cytotoxicity indicates that the membrane antigen is native, 
triple helical collagen. The correlation between the immunofluorescence titer 
and  the  radioimmunoassay titer  suggests  that  the  antibody  prepared  with 
denatured pepsin-treated type M collagen is able to bind both the denatured and 
native forms of the molecule. 
In  contrast,  there  is  a  disparity  between the  radioimmunoassay and  the 
immunofluorescence titers of the antibodies to type I collagen. One explanation 
for this disparity and the inability of antitype I collagen to elicit C-mediated 
cytotoxicity is that there is a  paucity of type I collagen molecules on the cell 
membrane. Another possible explanation is that these antibodies to denatured 
type I collagen have a low affinity for the native collagen molecule. Antibodies 
which are prepared with extracted,  denatured type I  collagen are primarily 
directed to the nonhelical amino and carboxyterminal portions of a-chains, most 
often the a2-chain (18-20),  and have a low affinity for the native molecule (20). 
Since we have not determined the affinity of the type I collagen antiserum for 
the native collagen molecule, or if the membrane-bound type I collagen is the 
native molecule, we can not distinguish between the aforementioned possibili- 
ties. The inability of antiserum to type I collagen to effect C-mediated cytotoxic- 
ity  can  not  be  due  either to  insufficient titers  of antibody,  since  a  sixfold 
increment of titer still did not induce cytotoxicity, or to the failure to bind C, 
since CF titers were comparable to the radioimmunoassay titers. 
Previous studies of cell membrane collagen (1-3) have used acid or neutral 
salt  extractable collagen in the preparation  of anticollagen antibodies.  Such 
preparative methods yield only type I collagen (7), and, thus, these studies have 
presumably utilized antiserum to type I collagen. Assuming that the antiserum 
utilized was to type !  collagen, these studies indicate that type I  collagen is 
membrane bound in chick (1), rat (2), and mouse L-cell fibroblasts (3). Our data 
indicate that  type I  collagen is  also  bound to  the normal human fibroblast 
membrane, and, thus, is both a membrane-bound and an extracellular protein. 
The previous studies also demonstrated that a species-specific antiserum to type 
I collagen was strongly cytotoxic to chick fibroblasts (1), only weakly cytotoxic 
for rat fibroblasts  (2),  and had little cytotoxicity for rat osteoblasts  (2).  The 
cytotoxic reaction with antibodies to type M collagen also appears to be species 
specific,  since these  antibodies were not cytotoxic for cultured chick tendon 
fibroblasts  but  were  cytotoxic for  cultured  human  tendon  cells.  Thus,  the 
predominant membrane-bound type of collagen may vary in different species 
and in different tissues. 
Although type I collagen and type M collagen could be demonstrated on the 
cell membrane, it was not clear whether the collagens were in the process of 
being secreted or were a stable membrane protein. The fact that type I collagen 
is the major collagen synthesized and secreted by cultured human fibroblasts, 
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that the collagens detected are membrane bound. This conclusion is supported 
by the failure  of antibodies to human  fibroblast collagenase,  another  protein 
secreted by the fibroblast, to evoke C-mediated cytotexicity. 
The results suggest similarities between the collagens and the immunoglobu- 
lins. Although IgG is the major humoral antibody secreted by lymphocytes and 
plasma  cells,  IgM  is the  primary  membrane-bound  immunoglobulin  (21).  So 
also, type I  collagen is the major secreted collagen and extracellular  fibrillar 
collagen  comprising  80-90%  of the  collagen  synthesized by fibroblasts,  while 
type  M  collagen  may  be  the  major  collagen  detected  on  the  cultured  skin 
fibroblast membrane. 
These studies have relevance to human connective tissue diseases (22). Anti- 
bodies to collagen have been detected in the serum and joint fluid of patients 
with rheumatoid arthritis  (23), in the serum from lupus erythematosis (23), and 
in  the  serum  from  patients  with  emphysema  (24).  Antibodies  to  fibroblast 
membranes which are cytotoxic at high concentrations have been shown to be 
immunostimulatory  at  low concentrations  (16).  It  is possible that  antibodies 
directed against type M collagen in vivo may be pathogenic in these diseases by 
either C-mediated cell destruction at high antibody titers or stimulating fibrosis 
at low antibody titers. 
Summary 
Collagen, the major extracellular matrix protein, is also a membrane protein. 
Two types of collagen are detected on the normal human fibroblast membrane in 
culture,  type I  collagen  and  a  new immunologically  and  chemically  distinct 
collagen, type M  (membrane) collagen.  Antibodies to type M collagen elicited 
complement-mediated cytotoxicity, which could be blocked by pretreatment  of 
the  cells  with  bacterial  collagenase  or  the  antibody  with  type  M  collagen. 
Pretreatment of the cells with other proteolytic enzymes or the antibody with 
type I collagen or type III collagen had no effect on this complement-mediated 
cytotexicity.  Although  type  I  collagen  is  the  major  collagen  synthesized  by 
normal  human  fibroblasts type M  collagen may be the  major cell membrane 
collagen and may be a  major cell membrane component. 
We thank Doctors A. Eisen, J. Jeffrey, and J. Uitto for their many helpful suggestions. 
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